You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.
keywords > Investigative Techniques > Epidemiologic Methods > Epidemiologic Research Design > Single-Blind Method
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.